MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41380-025-03032-x

Медицинская библиотека · Molecular psychiatry · 2025

Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions.

Dardani Christina, Robinson Jamie W, Jones Hannah J, Rai Dheeraj, Stergiakouli Evie, Grove Jakob, Gardner Renee, McIntosh Andrew M, Havdahl Alexandra, Hemani Gibran, Davey Smith George, Richardson Tom G, Gaunt Tom R, Khandaker Golam M

СтатьяПеревод в очереди

Аннотация

Immune dysfunction is implicated in the aetiology of psychiatric, neurodevelopmental, and neurodegenerative conditions, but the issue of causality remains unclear impeding attempts to develop new interventions. Using genomic data on protein and gene expression across blood and brain, we assessed evidence of a potential causal role for 736 immune response-related biomarkers on 7 neuropsychiatric conditions by applying Mendelian randomization (MR) and genetic colocalisation analyses. A systematic three-tier approach, grouping biomarkers based on increasingly stringent criteria, was used to appraise evidence of causality (passing MR sensitivity analyses, colocalisation, False Discovery Rate and Bonferroni thresholds). We provide evidence for a potential causal role of 29 biomarkers for 7 conditions. The identified biomarkers suggest a role of both brain specific and systemic immune response in the aetiology of schizophrenia, Alzheimer's disease, depression, and bipolar disorder. Of the identified biomarkers, 20 are therapeutically tractable, including ACE, TNFRSF17, SERPING1, AGER and CD40, with drugs currently approved or in advanced clinical trials. Based on the largest available selection of plasma immune-response related biomarkers, our study provides insight into possible influential biomarkers for the aetiology of neuropsychiatric conditions. These genetically prioritised biomarkers now require examination to further evaluate causality, their role in the aetiological mechanisms underlying the conditions, and therapeutic potential.

Для цитирования: Dardani Christina, Robinson Jamie W, Jones Hannah J, Rai Dheeraj, Stergiakouli Evie, Grove Jakob, Gardner Renee, McIntosh Andrew M, Havdahl Alexandra, Hemani Gibran, Davey Smith George, Richardson Tom G, Gaunt Tom R, Khandaker Golam M. Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions.. Molecular psychiatry. 2025. DOI: 10.1038/s41380-025-03032-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.